Ankur Mishra
Internal Medicine · Iowa City, IANPI 1619223880
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 39 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 14 manufacturers reported payments, led by Johnson & Johnson at 34.2% of the total. Reporting peaked in 2019 at $1,343 and has fallen 84.1% since, to $213 in 2025. Among internal medicine clinicians in IA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 39 payments — averaging $89.39 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$1K
- AbbVie$417
- Vifor Pharma, Inc.$409
- AstraZeneca$369
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$216
- Edwards Lifesciences$213
- plus $669 from 8 others
What the payments were for
- Food & beverage$3,486100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson | 14 | $1,193 |
| AbbVie(2 entities) | 7 | $417 |
| Vifor Pharma, Inc. | 4 | $409 |
| AstraZeneca(2 entities) | 3 | $369 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 2 | $216 |
| Edwards Lifesciences | 1 | $213 |
| Amgen | 1 | $124 |
| Bayer | 1 | $100 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $98 |
| Melinta Therapeutics, LLC | 1 | $97 |
| Actelion Pharmaceuticals US, Inc. | 1 | $97 |
| Fresenius USA Marketing, Inc. | 1 | $86 |
| SK Life Science, Inc. | 1 | $50 |
| Sunovion Pharmaceuticals Inc. | 1 | $18 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$3,486 in reported general payments places this provider in the 90th percentile of 583 internal medicine providers in Iowa.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 14 | $221 |
| Cefdinir | 13 | $163 |
| Oxycodone Hcl | 15 | $34 |
Paid to pharmacies, not to this prescriber.
Other internal medicine in Iowa City
- Madalyn WalshIowa City$80K
- Aziz HammoudIowa City$29K
- Mohammed MhannaIowa City$15K
- Sruti Prathivadhi-BhayankaramIowa City$6K
- Stephanie IvinsIowa City$2K
- Aneet KaurIowa City$2K
- Alexander GarzaIowa City$1K
- Mark JohnsonMason City$223K
- Mark CarlsonSioux City$174K
- Alan KricsfeldCouncil Bluffs$49K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.